Influence of atrial fibrillation on plasma von Willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure

被引:30
作者
Freestone, Bethan [1 ]
Gustasson, Finn
Chong, Aun Yeong [1 ]
Corell, Pernille [2 ]
Kistorp, Caroline [3 ]
Hildebrandt, Per [4 ]
Lip, Gregory Y. H. [1 ]
机构
[1] City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7HQ, W Midlands, England
[2] Frederiksberg Univ Hosp, Dept Cariol & Endocrinol E, Frederiksberg, Denmark
[3] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark
[4] Roskilde Univ Hosp, Dept Med, Roskilde, Denmark
关键词
atrial fibrillation; heart failure; N-terminal pro B-type natriuretic peptide; von Willebrand factor;
D O I
10.1378/chest.07-2557
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Endothelial dysfunction is present in patients with heart failure (HF) due to left ventricular systolic dysfunction, as well as in patients with atrial fibrillation (AF) who have normal cardiac function. it is unknown whether AF influences the degree of endothelial dysfunction in patients with systolic HF. Methods: We measured levels of plasma von Willebrand factor (vWF) and E-selectin (as indexes of endothelial damage/dysfunction and endothelial activation, respectively; both enzyme-linked immunosorbent assay) in patients with AF and HF (AF-HF), who were compared to patients with sinus rhythm and HF (SR-HF), as well as in age-matched, healthy, control subjects. We also assessed the relationship of vWF and E-selectin to plasma N-terminal pro B-type natriuretic peptide (NTpro-BNP), a marker for HF severity and prognosis. Results: One hundred ninety patients (73% men; mean age, 69.0 +/- 10.1 years [+/- SD]) with systolic HF were studied, who were compared to 117 healthy control subjects: 52 subjects (27%) were in AF, while 138 subjects (73%) were in sinus rhythm. AF-HF patients were older than SR-HF patients (p = 0.046), but left ventricular ejection fraction and New York Heart Association class were similar. There were significant differences in NT-proBNP (p < 0.0001) and plasma vWF (p = 0.003) between patients and control subjects. On Tukey post hoe analysis, AF-HF patients had significantly increased NT-proBNP (p < 0.001) and vWF (p = 0.0183) but not E-selectin (p = 0.071) levels when compared to SR-HF patients. On multivariate analysis, the presence of AF was related to plasma vWF levels (p = 0.018). Plasma vWF was also significantly correlated with NT-proBNP levels (Spearman r = 0.139; p = 0.0117). Conclusions: There is evidence of greater endothelial damage/dysfunction in AF-HF patients when compared to SR-HF patients. The clinical significance of this is unclear but may have prognostic value.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 27 条
[1]   Endothelial dysfunction in patients with heart failure: Relationship to disease severity [J].
Bank, AJ ;
Lee, PC ;
Kubo, SH .
JOURNAL OF CARDIAC FAILURE, 2000, 6 (01) :29-36
[2]   Impact of atrial fibrillation on the risk of death [J].
Benjamin, EJ ;
Wolf, PA ;
D'Agostino, RB ;
Silbershatz, H ;
Kannel, WB ;
Levy, D .
CIRCULATION, 1998, 98 (10) :946-952
[3]   Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin [J].
Chong, AY ;
Lip, GYH ;
Freestone, B ;
Blann, AD .
EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (02) :167-172
[4]   Endothelial dysfunction and damage in congestive heart failure - Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide [J].
Chong, AY ;
Blann, AD ;
Patel, J ;
Freestone, B ;
Hughes, E ;
Lip, GYH .
CIRCULATION, 2004, 110 (13) :1794-1798
[5]   Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation [J].
Conway, DSG ;
Pearce, LA ;
Chin, BSP ;
Hart, RG ;
Lip, GYH .
CIRCULATION, 2003, 107 (25) :3141-3145
[6]   Effect of atrial fibrillation on plasma NT-proBNP in chronic heart failure [J].
Corell, Pernille ;
Gustafsson, Finn ;
Kistorp, Caroline ;
Madsen, Lene Helleskov ;
Schou, Morten ;
Hildebrandt, Per .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 117 (03) :395-402
[7]   Expression and distribution of brain natriuretic peptide in human right atria [J].
Doyama, K ;
Fukumoto, M ;
Takemura, G ;
Tanaka, M ;
Oda, T ;
Hasegawa, K ;
Inada, T ;
Ohtani, S ;
Fujiwara, T ;
Itoh, H ;
Nakao, K ;
Sasayama, S ;
Fujiwara, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) :1832-1838
[8]   Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [J].
Dries, DL ;
Exner, DV ;
Gersh, BJ ;
Domanski, MJ ;
Waclawiw, MA ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (03) :695-703
[9]  
Galatius Soren, 2002, Am Heart J, V144, pE2, DOI 10.1067/mhj.2002.123841
[10]   Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population [J].
Groenning, BA ;
Raymond, I ;
Hildebrandt, PR ;
Nilsson, JC ;
Baumann, M ;
Pedersen, F .
HEART, 2004, 90 (03) :297-303